Acceptability of medicines in children and caregivers affects safety and effectiveness of 26 medicinal treatments. The pharmaceutical industry is required to demonstrate acceptability 27 of new paediatric formulations in target age groups as an integrated part of the development 28 of these products (P. Kozarewicz, 2014) . Two questions arise when trying to tackle this task: (Table 1) , and it is based on a more extensive review article by Liu et al. (2014) .
37
Gaps in knowledge are highlighted in order to stimulate further research (F. Liu et al., 2014) .
38
In some areas, findings from studies conducted in adult populations may provide useful 39 guidance for paediatric development and this is also discussed.
41
Tablets and capsules are the most commonly developed dosage forms for adult populations.
42
Efforts have been made in recent years to understand the relationship between acceptable 43 tablet sizes and the age group of children. However, insufficient data has been reported so 44 far to draw a conclusion or recommendation on the right tablet size for the right age group 45 which is also driven by indication, motivation of the patient and carer, counselling from health Mini-tablets (2-4 mm) were reported to be acceptable for children from 6 months of age (V. Klingmann et al., 2013) . Acceptability of tablets from 5 mm to 8 mm in size was evaluated in children from 1 to 11 years old in mixed age groups. Results from these studies were inconclusive as evidence for acceptability of tablets of different sizes in different age groups.
Shape
No report was found as to how tablet shape affects acceptability in children. Studies in adult populations show that patients' preference of tablet shape is associated with its size. Generally, small tablets are preferred to be arched round and medium and large tablets are preferred to be oblong or oval.
Film coating
Film coated and uncoated mini-tablets were both tested in children and two incidents of coughing or chocking were noted associating to coated tablets (V. Klingmann et al., 2013; S. A. Thomson et al., 2009 ). However, there is a lack of direct comparison of coated and uncoated tablets on swallowing performance in children.
Capsule

Comparison with tablet
Direct comparison of acceptability of capsules with tablets in children has not been reported. Studies in adults show conflicting results; however, general caution when taking capsules was recommended due to the possibility of adhesion of the hydrated gelatin shell to oesophagus.
Size
Acceptability of capsules in children in relation to size has not been reported. Studies in adults show that oesophageal transit of capsules was not affected by capsule size, in contrast to the significant influence of tablet size on its transit.
Density
Effects of capsule density on swallowability in children were not reported. Studies in adults show that heavy capsules pass through the oesophagus significantly faster than light capsules.
Liquid
Taste Many reports and review articles have established that taste is fundamentally important in acceptability of liquid medicines in children.
Smell
The smell of a liquid has been associated to its flavour and could contribute to the palatability of liquid medicines. Limited data has been reported to link medication odour to acceptability in children.
Viscosity
No report was found on the effects of the viscosity of liquid medicines on acceptability and ease to swallow in children. Studies in adult populations and patients with dysphagia show that viscosity is associated to patient's perception of palatability of liquids. Thick liquids are deemed as unpleasant; however, these could improve swallowing safety in dysphagia patients.
Texture
The texture of a liquid, especially grittiness and mouth feel of suspensions has been linked to particle size. The effects on acceptability in children have not been extensively studied.
Volume
The ideal volume of liquid medicines should be swallowable in one unit. The average volume of liquid in one swallow is reported to be 4.5 ml in children from 15 months to 3.5 years of age (D. V. Jones and C. E. Work, 1961). Very small volumes of oral liquids could be related to issues in dosing accuracy in children.
Oral flexible solid dosage forms
Multiparticulates
These are generally acceptable in children due to enhanced palatability and flexibility in administration such as mixing with semi-solid food. Grittiness and mouth feel are the main concerns in acceptability in children. The administration is considered to be time-consuming due to the need of reconstitution, which poses challenges to parents and carers.
Dispersible and effervescent tablets
Acceptability of dispersible tablets has been tested in children from 3 months to 8 years of age. These are generally more favourable compared to oral liquids such as syrup. However, the risk of tooth erosion needs to be considered for long-term use. The high quantity of sodium content in these formulations is associated to increased cardiovascular incidents in adults. The effect on long-term health in children has not been studied.
